Since 2012, Fuad El-Hibri has served as the executive chairman of Emergent BioSolutions in Gaithersburg, Maryland, a biopharmaceutical company that develops vaccines. Earlier in his career, Fuad El-Hibri received an Ernst & Young Entrepreneur of the Year Award.
Each year, the accounting firm recognizes individuals and businesses that create innovative value for their stakeholders and enhance the life of their communities and the world. Established in 1986 as an honorary presentation in Milwaukee, Wisconsin, the awards are now given in more than 60 countries. Each nation’s winners compete for the World Entrepreneur of the Year prize.
People who wish to nominate an entrepreneur must complete an extensive application that provides financial information on their company, such as annual sales for three years, total income, and assets.
Nominators must then delineate the nominee’s personal qualities. For example, how well does the nominee uphold their standards and deal with setbacks? How do they promote sustainability? To what extent does the nominee nurture alliances and measure progress toward strategic goals?
In addition, the Ernst & Young judges look for business models that disrupt existing industry practices. They also examine the nominee’s ability to build market share, expand globally, and inspire their organization.